Revolution Medicines, Inc. (RVMD)
Revolution Medicines (RVMD) sees significant social media buzz with mentions in Google's Q4 [----] 13F filings and positive analyst sentiment, despite recent price declines.
About Revolution Medicines, Inc.
Revolution Medicines, Inc. is a biotechnology company focused on precision oncology.
Revolution Medicines, Inc. uses the ticker $RVMD for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Revolution Medicines, Inc. (RVMD) Galaxy Score™ is up 76.92% from the previous month.
- Revolution Medicines, Inc. (RVMD) sentiment is up 185.71% from the previous week.
- Revolution Medicines, Inc. (RVMD) engagements is up 399.54% from the previous week.
- Revolution Medicines, Inc. (RVMD) posts created is up 66% from the previous week.
Price: $96.30
Price 24-Hour Time-Series Raw Data
The stock price has declined following Merck's withdrawal of acquisition talks, but recent whale buying in call options indicates potential short-term upward movement, supported by positive sentiment around clinical data and analyst upgrades.
24-Hour: -1.56% 7-Day: -1.23% 30-Day: -19.93%
1-Year High: $123.30 on 2026-01-15
1-Year Low: $31.10 on 2025-04-08
AltRank: [---]
AltRank 24-Hour Time-Series Raw Data
Revolution Medicines, Inc. (RVMD) is currently AltRank #787 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] +86
[--] Month: [---] +660
[--] Months: [---] [---]
[--] Year: [---] +305
1-Year High: [-----] on 2025-03-03
1-Year Low: [--] on 2026-01-10
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +17
[--] Month: [--] +30
[--] Months: [--] +15
[--] Year: [--] +20
1-Year High: [--] on 2025-11-14
1-Year Low: [--] on 2025-04-13
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +400%
[--] Month: [---------] -36%
[--] Months: [---------] +469%
[--] Year: [---------] +175%
1-Year High: [-------] on 2026-01-08
1-Year Low: [---] on 2025-04-13
Engagements by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [------] YouTube: [--]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -29%
[--] Month: [-----] +32%
[--] Months: [-----] +143%
[--] Year: [-----] +211%
1-Year High: [-----] on 2026-01-09
1-Year Low: [--] on 2025-08-09
Mentions by network (24h): News: [--] TikTok: [--] Reddit: [--] X: [---] YouTube: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Revolution Medicines, Inc. (RVMD) in the last [--] hours which is down 15% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] -21%
[--] Month: [-----] +18%
[--] Months: [-----] +52%
[--] Year: [-----] +244%
1-Year High: [---] on 2026-01-09
1-Year Low: [--] on 2025-04-24
The most influential creators that mention Revolution Medicines, Inc. in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @ohadhammer | [--] | [-----] | [--] | [-----] |
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @TheTechInvest | [--] | [------] | [--] | [---] |
| @aayushtrades | [--] | [---] | [--] | [---] |
| @chaotropy | [--] | [---] | [--] | [---] |
| @suninvestor | [--] | [---] | [--] | [--] |
| @Stella63592 | [--] | [--] | [--] | [--] |
| @keisan_15 | [--] | [---] | [--] | [--] |
| @fogkkkeh40155 | [--] | [--] | [--] | [--] |
| @seedy19tron | [--] | [------] | [--] | [--] |
Sentiment: 76%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 76%
Daily Average: 75%
[--] Week: 100% +65%
[--] Month: 62% -9%
[--] Months: 62% -31%
[--] Year: 62% -22%
1-Year High: 100% on 2025-04-24
1-Year Low: 26% on 2025-04-13
Most Supportive Themes:
- Positive Clinical Data: (42%) Revolution Medicines, Inc. Common Stock (RVMD) shows promising clinical data in its latest reports.
- Analyst Upgrade: (29%) Bank of America has upgraded its price target for Revolution Medicines, indicating increased confidence.
- Increased Trading Volume: (8%) Revolution Medicines is experiencing a significant rise in trading volume, suggesting heightened investor interest.
Most Critical Themes:
- Market Sentiment and Valuation Concerns: (21%) Negative market sentiment and concerns about valuation relative to competitors are impacting the stock price.
Social Dominance: 0.00956%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00956%
Daily Average: 0.017%
[--] Week: 0.015% -0.011%
[--] Month: 0.011% -0.058%
[--] Months: 0.011% +0.0044%
[--] Year: 0.011% +0.002%
1-Year High: 0.158% on 2026-01-09
1-Year Low: 0.0029% on 2025-08-09
Market Dominance: 0.021%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.021%
Daily Average: 0%
1-Year High: 0.247% on 2025-03-31
1-Year Low: 0.00835% on 2025-08-11
Market Cap: $18,618,630,420
Market Cap 24-Hour Time-Series Raw Data
Current Value: $18,618,630,420
Daily Average: $10,282,472,865
[--] Week: $18,618,630,420 -0.47%
[--] Month: $18,618,630,420 -20%
[--] Months: $18,618,630,420 +175%
[--] Year: $18,618,630,420 +148%
1-Year High: $23,830,532,362 on 2026-01-15
1-Year Low: $5,787,481,838 on 2025-04-08
Top Revolution Medicines, Inc. Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"$azn $pfe $jnj $nvs $bmy $gsk $abbv $mrk $sny #biotech #pharma #cancer $nvo $lly $xbi $amgn $rhhby $aapl $tsla $abvx $rvmd $sgmo 1/🚨 This short and excellent FT article tells the tale of AstraZenecas huge success story and how $AZN is paving its way towards fulfilling its ambitious corporate goal of $80B in revenue by [----]. This massive achievement is based mainly on a fantastic track record of [--] https://t.co/WfYnmDHjTV 1/🚨 This short and excellent FT article tells the tale of AstraZenecas huge success story and how $AZN is paving its way towards fulfilling its ambitious corporate goal of"
X Link @HalevyMike 2026-02-16T15:56Z [----] followers, [---] engagements
"Google's top [--] holdings for Q4 [--]. AST SpaceMobile (ASTS) . 4G/5G . [--]. Planet Labs (PL) . . [--]. Revolution Medicines (RVMD) . RAS KRAS . [--]. Arm Holdings (ARM) IoT ARM IP . (SoftBank Alphabet ) [--]. Freshworks (FRSH) CRM . Salesforce . [--]. UiPath (PATH) RPA(Robotic Process Automation) . . [--]. GitLab (GTLB) DevOps . CI/CD (GitHub ). [--]. Tempus AI (TEM) AI . . [--]. DexCom (DXCM) (CGM) . . [--]. Maze Therapeutics ( ). Alphabet (Space) IT . https://twitter.com/i/web/status/2023333653229736417 https://twitter.com/i/web/status/2023333653229736417"
X Link @BUZZ__tiab 2026-02-16T09:48Z [----] followers, [---] engagements
"RAS landscape from $ERAS' corporate deck. Surprisingly sparse imo maybe because of technical issues (finding good inhibitors tri-complex or degraders) Three pure plays are $RVMD (P3 $18.6B) $ERAS (P1 $3.7B) and $ANL (P1 just started $350M) with three pan-RAS programs that look mechanistically similar. $ERAS and $ANL have more potent compounds and need lower doses but still unclear if this leads to a different clinical profile. https://twitter.com/i/web/status/2023333028278554956 https://twitter.com/i/web/status/2023333028278554956"
X Link @ohadhammer 2026-02-16T09:46Z [----] followers, [----] engagements
"Theres a reason why $GOOG #1 position is $ASTS 🧇 @AST_SpaceMobile @AbelAvellan @scottwisniews 🧇🧇🧇🧇🧇🧇🧇🔥🚀 $GOOGL 13F filling for Q4 2025: Their largest positions: [--] - AST SpaceMobile $ASTS 😏 [--] - Planet Labs PBC $PL [--] - Revolution Medicines $RVMD [--] - Arm Holdings $ARM [--] - Freshworks $FRSH [--] - UiPath $PATH 👀 Of course we hold Google itself but our largest position is also $ASTS. https://t.co/efsZgTOzyK $GOOGL 13F filling for Q4 2025: Their largest positions: [--] - AST SpaceMobile $ASTS 😏 [--] - Planet Labs PBC $PL [--] - Revolution Medicines $RVMD [--] - Arm Holdings $ARM [--] - Freshworks $FRSH 6"
X Link @Highpeaksventur 2026-02-15T19:03Z [---] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing